WNT5A and non-small cell lung carcinoma: Additionally, the exosome-free serum of LUAD patients had notably higher levels of WNT5A than LUSC patients, indicating that the two subtypes of NSCLC have distinct extracellular WNT5A profiles suggesting that the location of WNT5A may play a significant role in the clinical outcome.